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Abstract
Background: Preterm births (as a proportion of all births) have been increasing in many countries. There is
growing evidence of increased risk of preterm birth following excisional treatment of the cervix. We estimate
the number of preterm births attributable to excisional treatments with a length of 10 mm or more in England.
Methods: Case–control study nested in a record linkage cohort of women with a histological sample at 13 hospitals in
England. We combined observed age at first excisional treatment in our cohort with the weighted distribution of excision
length from the case–control study to estimate the length distribution by age at first treatment among the cohort. The
number of births after excision for each 5-year age group was estimated using national fertility data; published absolute
risks of preterm (<37 gestational weeks) and very preterm birth (<32 weeks) were applied to these to estimate the
number of preterm births per 100 women treated. Excess preterm births were estimated assuming all treatments were
small. The attributable risk of preterm birth following excisional treatment in England was estimated.
Results: The majority of first excisional treatments at colposcopy were small (47.5 %) or medium (39.1 %), 9.5 % were
large and 4.1 % were very large excisions. 4.0 % of women treated before birth had more than one excisional treatment.
Thus based on our cohort of 10,711 treated women and the length of treatment observed in the case control study we
estimate an excess of 240 preterm births (including 57 very preterm) or 2.2 (including 0.5 very preterm) per 100 women
treated. At a population level (for England) we estimate that 39,101 women aged 20–39 would be treated each year and
that these treatments will lead to an excess of 840 preterm births (including 196 very preterm) in England each year.
Conclusions: Assuming associations between preterm birth and treatment for cervical disease are causal;
we estimate that an excess 840 (2.5 %) preterm birth in England each year are due to excisional treatments of 10 mm
or more. Those that go on to become pregnant should be closely monitored during antenatal period to reduce their
risk of preterm birth.
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Background
A growing body of literature suggests that women who
undergo treatment for cervical disease are at increased risk
of preterm birth, particularly when the length of the tissue
excised is greater than or equal to 10 mm [1–8]. In
England, the absolute risk of preterm birth among treated
women increased with the length of excision from 7.5 %
(with length <10 mm) to 18 % in those with excisions
greater than 20 mm [8].
Although the risk of preterm birth following excision is
often cited as a reason for not offering cervical screening to
young women, we are not aware of any papers formally cal-
culating the risk associated with screening per se. Further
whilst preterm births (as a proportion of all births) have
been increasing in many countries [9, 10] it is unclear what
proportion may be attributable to prior treatment for
cervical disease.
In this study, we estimate the number of preterm births
among women with cervical excisional treatments,
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accounting for age at excision and length of excision, in
order to estimate the number and proportion of preterm
births in England attributable to cervical tissue excision of
10 mm deep or more.
Methods
Subjects
Women with cervical histology between April 1988 and
December 2011 were identified from clinical records in 13
National Health Service (NHS) hospitals (see acknowledg-
ments). The women were linked to hospital obstetric
records between April 1998 and March 2011 for the whole
of England using their NHS number (a unique identifier)
and date of birth by HES (Hospital Episode Statistics), a
data warehouse containing details of all admissions to NHS
hospitals in England [11]. Minimal details were obtained
for this cohort: date of first and last attendance to colpos-
copy and whether they had a punch biopsy or excisional
treatment at these appointments. Excisional treatments
were defined as: LLETZ, laser excision, non specified cone
excision or knife cone biopsy. Details of women included in
this study in comparison to published manuscripts [8, 12]
are presented in Fig. 1.
From this cohort we identified women who had at least
one singleton live birth with a gestational age of 20–42
weeks. We then selected the first singleton preterm birth
(gestational age of 20–36 completed weeks) in each
woman and frequency matched these to singleton term
births (38–42 completed weeks) in women with no pre-
term births. Births at 37 weeks gestational age were
excluded when performing the matching to allow a clear
divide between term and preterm births. Full details on
the study design have been published previously [8, 12].
From HES records we obtained detailed obstetric informa-
tion. Hospitals entered colposcopy details into a study
database and additionally submitted anonymised path-
ology reports to Barts Health NHS Trust. Pathology
reports were entered into the study database by two
trained individuals (AP and TP) to ensure measurements
were entered in a standardised way, facilitating the identifi-
cation of the length, thickness and circumference of speci-
mens. Participating pathology departments confirmed that
usual practice was to record the length of the specimen first
on the pathology reports. Individuals searching for and cod-
ing colposcopy information were blind to the case–control
status of the women.
Women were not eligible for the case–control study
if detailed colposcopy information was not available, if
colposcopy records were known to be incomplete, if
the only pathology sample reported was non-cervical
or if the woman was diagnosed with cervical cancer at
any time. We also excluded one woman who was re-
corded as being sterilized whilst pregnant. Details of
women excluded from the case–control study have
been published previously [8]. Here we further exclude
the following women: those attending colposcopy but
not receiving excisional treatment, those who had their
first treatment aged 40 and over and those with un-
known length of their only excisional treatment (see
Fig. 1). In our previous publication births as a result of
a high risk pregnancy (defined elsewhere [8]) were ex-
cluded; however they are included here to determine
the age at first excisional treatment, to ensure the sam-
ple is representative of the general population.
Ethical approval
This study was approved by the Brompton, Harefield, and
NHLI research ethics committee, Charing Cross Hospital,
London (study reference number: 09/h0708/65). Since this
was a retrospective linkage study using routinely recorded
Fig. 1 Inclusions and exclusions from the study
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data, informed consent was not required by the research
ethics committee. All data received by the researchers
were anonymous.
Statistical methods
To assess the concordance between dates at first col-
poscopy procedure recorded in the cohort and the
case–control study we selected all women recorded in
the case–control study as having an excisional treat-
ment as their first colposcopic procedure. We used a
paired sample t-test to compare the age at first colpo-
scopic appointment in the case–control study and the
cohort study.
Length of excision was defined as the distance from
the distal or external margin to the proximal or internal
margin of the excised specimen, as defined by the IFCPC
nomenclature [13]. The length of treatment was coded
as per the pre-specified statistical analysis plan: excision
with a length of <10 mm (small), 10–14 mm (medium),
15–19 mm (large) and ≥20 mm (very large). When the
excision was piecemeal, the largest fragment length was
used. For women with more than one excisional treatment
(n = 106), if the treatments were within a year (n = 40), the
lengths were summed, as is it is extremely unlikely there
would be a birth between the two treatments. Length of
treatments that were more than a year apart (n = 66) were
summed at the time of the later treatment.
The distribution of length of excisional treatment was
calculated using all available data for each age group (<20,
20–24, 25–29, 30–34, 35–39) in the case–control study,
weighted using the inverse probability of selection into the
case–control study to reflect the distribution of cases and
eligible controls in the cohort. These data were combined
with cohort data on the number of women in each age
group who underwent an excisional treatment between
April 1988 and December 2011. Using these data we esti-
mate by age group the number of women in the cohort
who had an excisional treatment in each length category.
We assume that single excisions with unknown length have
the same distribution as those with known length in the
same age group. Women with an unknown length of first
treatment but known length of second treatment within a
year were assigned the median length observed among
women who had multiple treatments within a year for the
unknown length. For women with multiple treatments
which were at least a year apart, if either treatment had an
unknown length they were proportionally assigned to the
length categories of treated women who had multiple treat-
ments within the same age group.
Using age-specific fertility rates for England from 2010,
[14] we estimated the expected number of future births
per woman in 5-year age groups. We have previously
shown that the increased risk of preterm birth remains for
all future births, not just the first birth after colposcopy
[15]. Therefore we applied published absolute risks [8]
of preterm (20–36 gestational weeks) and very preterm
(20–31 gestational weeks) births for each length cat-
egory to the expected number of future births for
women in each age group. The absolute risks of a preterm
birth were 7.5 % following small excisions, 9.6 % following
medium, 15.3 % following large and 18.0 % following very
large excisions (for very preterm they were 2.0 %, 2.3 %,
3.6 % and 6.4 % respectively) [8]. Women with multiple ex-
cisional treatments not within a year of each other were
assigned the absolute risk appropriate for their first treat-
ment length from the age at their first excisional treatment
to their second treatment, and the absolute risk associated
with the two treatment lengths summed from the age at
the second treatment. The expected number of preterm
births was then estimated assuming that all treatments
were small, to allow estimation of the excess risk of preterm
birth caused by deeper excisions.
To estimate the number of preterm births associated with
excisional treatments in England, it was necessary to esti-
mate the number of women per year who have excisional
treatments. For this we sourced the number of tests taken
and the result of these tests from routinely published
screening data for England in the financial year 2013/14
[16]. We then used previously published methodology [17]
to estimate (from the published data) the total number of
women aged 20–39 who had an excisional treatment in
financial year 2013/14. Full details on how this was esti-
mated can be found in Additional file 1, and the results in
Additional file 2: Tables S1 and Additional file 3: Table S2.
Analyses were carried out in STATA 12 (StataCorp.
College Station, Texas, USA).
Results
Information was available on 32,986 women with a histo-
logical sample taken under age 40 at colposcopy between
April 1988 and December 2011. From this cohort, around
two-fifths (n = 10,711) of the women with known treatment
at their first colposcopy (N = 26,235) were recorded as hav-
ing an excisional procedure at their first attendance to col-
poscopy. Most of these women (53.9 %) were aged 25–34
at their first treatment (Table 1). From the case–control
study 1079 women treated at colposcopy were eligible for
this analysis; of these 894 were treated on their first attend-
ance to colposcopy. This subset of women (n = 894) tended
to be younger than women in the cohort, with 70.2 %
treated age 20–29. This was expected, as women attending
colposcopy at a younger age are more likely to go on to
have a birth, and therefore be eligible for the case–control
study. Comparison of the data from the cohort with that
from the case–control study (for these 894 women) showed
that the age at first treatment agreed exactly for 49.2 % of
women and was within a month for an additional 32.8 %.
Only 4.3 % differed by over 6 months. There was no
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significant difference in the age distributions (paired t-test
p-value = 0.2319).
Estimated (weighted) age at first excisional treatment and
proportion in each excisional length category among
women in the cohort study is shown in Table 2. Overall the
majority of first excisional treatments at colposcopy were
small (47.5 %) or medium (39.1 %), 9.5 % were large and
4.1 % were very large excisions. Only 4.0 % of women
treated before giving birth are estimated to have had a
second excisional treatment more than a year after the first.
The estimated number of births following excisional treat-
ment by age group and the estimated excess preterm births
due to treatment can be seen in Table 3. Thus based on our
cohort of 10,711 treated women and the distribution of
treatment lengths observed in the case control study we
estimate an excess of 240 preterm births (including 57 very
preterm) or 2.2 (including 0.5 very preterm) per 100
women treated.
At a population level (for England) we estimate that
39,101 women aged 20–39 would be treated each year
(Table 4, and Additional file 1). We estimate that these
treatments will lead to an excess of 840 preterm births
(including 196 very preterm) in England each year
among women with excisional treatments with a length
of ≥10 mm.
Discussion
Based on the observed age at first excisional treat-
ment at colposcopy in women under age 40, the ob-
served length of tissue removed, age specific fertility
rates and the length specific absolute risks of preterm
birth we have estimated that treatment for cervical
disease leads to 2.2 preterm (0.5 very preterm) births
per 100 women treated under age 40. At a national
level this corresponds to 840 preterm births per year
in England.
Strengths and limitations
Our results are based on the assumption that the associ-
ation between preterm birth and treatment for cervical dis-
ease is causal. However lifestyle factors (such as smoking)
were not adjusted for when estimating the risks used in this
study, thus it is possible that residual confounding remains.
The distribution of age at first excisional treatment for
women in England is extrapolated from that observed in
our study and may not be representative of all women
currently being treated in England. For example, women
aged 20–24 are no longer invited for cervical screening in
England, so we expect the number of preterm births due
to excisional treatment among women in this age group to
be lower than the number estimated here. Only 2.7 % of all
treatments in the study were carried out before age 25, so
the impact on the number of preterm birth is likely to be
small.
Although the NHS hospital trusts providing data to this
study were self selected they did not differ (on the basis of
published data) from other colposcopy clinics in England
[8]. We therefore think it is justified to assume that the
observed distribution of excised tissue length can be
extrapolated to all women in England.
Due to the lack of routinely reported data, it was neces-
sary to estimate the number of women treated each year at
colposcopy in England. Our estimate (n = 39,101) is based
on routinely reported cytology and histology data, however
Table 1 Age among women whose first attendance to colposcopy resulted in excisional treatment. Comparison of cohort and
case–control data
Age at
treatment
Case–control study Treated at first
colposcopy in cohort
among those included
in the case–control
study
Cohort study
Treated at first colposcopy Treated at first colposcopy
N % N % N %
<20 20 2.2 18 2.0 167 1.6
20–24 286 32.0 286 32.0 2355 22.0
25–29 342 38.3 340 38.0 3417 31.9
30–34 181 20.2 191 21.4 2907 27.1
35–39 65 7.3 59 6.6 1865 17.4
Total 894 100 % 894 100 % 10711 100 %
Table 2 Estimated (weighted) age at first excisional treatment
by length of tissue removed among women in the cohort study
<10 mm 10–14 mm 15–19 mm 20 +mm Total
N % N % N % N %
<20 42.1 36.1 64.2 54.9 9.5 8.2 1.0 0.9 116.9
20–24 836.9 52.5 535.7 33.6 154.5 9.7 68.2 4.3 1595.3
25–29 957.8 42.0 974.4 42.8 238.3 10.5 108.4 4.8 2278.8
30–34 510.3 49.8 424.0 41.4 62.7 6.1 27.1 2.6 1024.0
35–39 140.5 58.5 56.7 23.6 32.6 13.6 10.5 4.4 240.3
Total 2487.6 47.3 2054.9 39.1 497.6 9.5 215.2 4.1 5255.3
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it is worth noting that the results are similar to twice the
number of CIN3 diagnoses in women under age 40
(n = 40,750) [18]. Diagnoses of CIN2 are not routinely
recorded or reported, but we think it sensible to as-
sume that the number diagnosed is similar to that of
CIN3 and that most of these women would have an
excisional treatment as a result. This gives us confi-
dence that our estimate of women treated at colpos-
copy each year is robust.
We have made assumptions regarding the length of
excision among samples where the measurements are
unknown, including those with multiple treatments. The
risk in those with unknown length was found to be simi-
lar to those with medium excisions [8] suggesting that
factors other than length (such as piecemeal excisions)
are responsible for missing values.
We have applied absolute risks of preterm birth to
all future births, not just the first following excisional
treatment. We believe this is justified since we have
shown that an increased risk of preterm birth remains
for all future births, not just the first birth following
treatment [15].
We have estimated the excess number of preterm
birth attributable to excisional by comparing the ob-
served length distribution in our study to a scenario
where all excisions have a length of less than 10 mm
(equivalent to the baseline risk in those attending col-
poscopy). We are not suggesting that clinical practice
should change to force all excisions to be small, we
are purely estimating the excess risk attributable to
excisions with a length greater than 10 mm.
Interpretation
Relative risks of preterm birth following large (17 +mm)
treatments compared to small treatments (≤10 mm)
have been reported to be between 1.74 [7] and 1.79 [3]
in Scandinavian populations and up to 2.4 in an English
population [8]. A meta-analysis [5] comparing untreated
women to those with excisions deeper than 10 mm
found the relative risk of preterm delivery to be 2.61
Table 3 Estimated preterm births due to excisional treatment of the cervical transformation zone
Estimated births
after first
treatment (N)
Preterm births Very preterm
births
(<37 gestational weeks) (20–31 gestational weeks)
Age at first
treatment
Women with
excisional
treatment
Estimated births
taking into account
length distribution*
Estimated births
assuming all
excisions ≥10
mm were small
Excess births
due to
treatments
Estimated
births taking
into account
length
distribution
Estimated
births
assuming all
excisions ≥10
mm were small
Excess births
due to
treatments
N %
<20 single
excision
167 1.6 323 31 24 7 8 6 1
20–24 single
excision
2355 22.0 4043 395 303 91 104 81 23
25–29 single
excision
3417 31.9 4332 428 325 103 111 87 24
30–34 single
excision
2907 27.1 1929 176 145 31 45 39 7
35–39 single
excision
1865 17.4 343 33 26 7 9 7 2
Total 10711 100 % 10970 1063 823 240 276 219 57
Table 4 Estimated number of women referred and treated at colposcopy due to cervical intraepithelial neoplasia grade 2 (CIN2+) or
worse diagnosis and the resulting excess preterm births each year in England
N screening tests: N referred to
colposcopy:
N referred
with mild
N referred
with mod+
N with CIN2+: Estimated excess number
of future preterm births
Estimated excess number
of future very preterm births
per woman
treated
in women
treated
per woman
treated
in women
treated
20–24 46,050 4,668 2,852 1,816 2037 0.04 79 0.01 20
25–29 566,057 46,468 27535 18933 20844 0.03 630 0.01 149
30–34 497,109 24,640 16178 8462 10004 0.01 108 0.00 22
35–39 446,807 16,086 11036 5050 6216 0.00 23 0.00 6
total 1,556,023 91,861 57,600 34,261 39,101 840 196
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(95 % CI 1.28–5.34), though a study from Belgium [19]
found even higher risks (RR = 4.55, 95 % CI:1.32–15.65).
The study in England [8] found that the absolute risk of
preterm birth among those who receive a diagnostic biopsy
(7.2 %, 95 % CI: 5.9 %–8.5 %) is similar to that of women
with small treatments (7.5 %, 95 % CI: 6.0 %–8.9 %). Never-
theless women attending colposcopy following an abnormal
cytology result are at a higher risk of preterm birth than the
general population in England, where the preterm rate in
England is 6.7 % [8]. This is most likely due to the shared
risk factors for preterm delivery and cervical disease.
An excess of 2.2 preterm births per 100 women treated
may not seem like much, however the average number of
births in England between 2000 and 2009 was 510,660 each
year and the preterm rate during this period was 6.7 % (or
33,168 births) [12]. Extrapolating the results observed in
this study to the whole of England, we would expect
840 preterm births a year (equivalent to 2.5 % of pre-
term births in England) to be due to excisional treat-
ments of length ≥10 mm.
The risk of preterm birth following treatment for cervical
disease can be considered a harm of cervical cancer screen-
ing. Nevertheless it needs to be considered against the
20,375 women under age 40 diagnosed and treated for car-
cinoma in situ of the cervix uteri (CIN3) in 2012 [18], many
of whom would have gone on to develop cervical cancer
without intervention.
Colposcopists will need to carefully consider whether
the benefits of a small excision outweigh the potential
risk of leaving diseased tissue on the cervix (i.e. positive
margins), risking the need for further treatment. Patients
who need a large excision of the cervix should be
informed about the risk of preterm birth. Close obstetric
monitoring is warranted for women who undergo large
excisional treatment and subsequently become pregnant,
particularly since recently published evidence suggests
that preterm birth in high risk pregnancies can be sub-
stantially reduced by measuring fibronectin levels and
assessing cervical length [20]. The extra costs of close
obstetric monitoring of these women will easily be offset
by the saving made in the reduction of preterm births,
which cost on average 1.47 % more than term babies up
to age 18 [21].
Conclusion
We estimate that 840 or 2.5 % of preterm births in England
each year are due to excisional treatments of 10 mm or
more. Clinicians (and in particular obstetricians) need to be
aware of whether women in their care have undergone
treatment of the cervical transformation zone. Those who
have must undergo close monitoring and further investiga-
tions with the aim of reducing the number of preterm
births among these women.
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